Viemed Healthcare

US Aging And Telehealth Will Expand Home Care

AnalystHighTarget

Not Invested

Community Contributor

Published

18 May 25

AnalystHighTarget's Fair Value

US$15.00

56.9% undervalued

18 May

US$6.46

-25.0%

-6.6%

-25.0%

-6.6%

You can edit this narrative until May 18 9:32 PM. Then, changes will post as Updates.

Author's Valuation

US$1556.9% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

US$15

56.9% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

16.72%

Healthcare Services revenue growth rate

0.22%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.78%

Calculation

US$28.38m

Earnings '28

24.45x

PE Ratio '28

US$693.90m

Market Cap '28

US$693.90m

Market Cap '28

38.34m

No. shares '28

US$18.10

Share Price '28

US$18.10 Share Price '28

Discounted to 2025 @ 6.78% p.a.

US$14.87

Fair Value '25